RYDAPT 25 mg/1
RYDAPT · CAPSULE, LIQUID FILLED · Novartis Pharmaceuticals Corporation
No Recall History
Plain English
RYDAPT is a capsule, liquid filled containing rydapt at 25 mg/1, taken oral. Manufactured by Novartis Pharmaceuticals Corporation.
Key Facts
- Brand Name
- RYDAPT
- Generic Name
- RYDAPT
- NDC Code (Product)
0078-0698- Manufacturer
- Novartis Pharmaceuticals Corporation
- Strength
- 25 mg/1
- Dosage Form
- CAPSULE, LIQUID FILLED
- Route
- ORAL
- Marketing Status
- Application #
- NDA207997
- Drug Class
- Kinase Inhibitor [EPC]
- Marketing Start
- 04/28/2017
Recall History
No Recall HistoryFrequently Asked Questions
What is RYDAPT used for?
RYDAPT contains RYDAPT. It is a capsule, liquid filled taken oral. Consult your doctor for specific uses.
Is RYDAPT a controlled substance?
RYDAPT is not classified as a controlled substance by the DEA.
What is the generic name for RYDAPT?
The generic name for RYDAPT is RYDAPT. There are no other listed brand versions of RYDAPT.
What is the NDC code for RYDAPT 25 mg/1?
The NDC (National Drug Code) for RYDAPT 25 mg/1 is 0078-0698, listed by Novartis Pharmaceuticals Corporation.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)